Storia in 4 fonti

Dow Jones Top Company Headlines at 1 PM ET: Moderna Shares Double on Success of mRNA Cancer Vaccine | Target ...

Moderna Shares Double on Success of mRNA Cancer Vaccine

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo16 h fa

Dow Jones Top Company Headlines at 1 PM ET: Moderna Shares Double on Success of mRNA Cancer Vaccine | Target…

Analog Devices' profit and revenue soar on accelerating AI data center demand; Unitree Robotics IPOs as mainland China's first humanoid-robot maker. Enterprise AI infrastructure capex remains robust, but OpenAI Q2 revenue disappoints vs Anthropic, signaling LLM market compression and geopolitical shift toward embodied AI.

originale

axios.com13 h fa

Moderna and Merck shares soar on mRNA cancer vaccine

The results come at a pivotal moment for Moderna and mRNA research.

Leggi questa versione →

Timeline cronologica

mercoledì 19 agosto 2026·morningstar.com
Dow Jones Top Company Headlines at 1 PM ET: Moderna Shares Double on Success of mRNA Cancer Vaccine | Target ...
Moderna Shares Double on Success of mRNA Cancer Vaccine
mercoledì 19 agosto 2026·fortune.com
Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…
The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

Dow Jones Top Company Headlines at 1 PM ET: Moderna Shares Double on Success of mRNA Cancer Vaccine | Target ...

Confronto fonti

Dow Jones Top Company Headlines at 1 PM ET: Moderna Shares Double on Success of mRNA Cancer Vaccine | Target…

Moderna and Merck shares soar on mRNA cancer vaccine

Timeline cronologica

Dow Jones Top Company Headlines at 1 PM ET: Moderna Shares Double on Success of mRNA Cancer Vaccine | Target ...

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in…

Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In Focus - Merck & Co (NYSE:MRK)

Dow Jones Top Company Headlines at 3 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...

Moderna and Merck shares soar on mRNA cancer vaccine

Dow Jones Top Company Headlines at 5 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...

Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In Focus - Merck & Co (NYSE:MRK)

Dow Jones Top Company Headlines at 7 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...